Seizures in pregnancy: Epilepsy, eclampsia, and stroke

Seminars in Perinatology

Volumn 37, Issue 4, 2013, Pages 207-224

  Hart, Laura A ^a   Sibai, Baha M ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Eclampsia; Epilepsy; Pregnancy; Seizure; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ENALAPRIL; ETIRACETAM; FOLIC ACID; GABAPENTIN; GLUCONATE CALCIUM; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; LABETALOL; LAMOTRIGINE; MAGNESIUM SULFATE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; WARFARIN;

ABNORMAL BEHAVIOR; ANEURYSM CLIP; ANTICOAGULATION; ARTERIOVENOUS MALFORMATION; ARTERY DISEASE; ATAXIA; AWARENESS; BLEEDING DISORDER; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BREAST FEEDING; CARDIAC DEPRESSION; CARDIOEMBOLIC STROKE; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLEFT LIP; CLEFT PALATE; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; CONVULSION; DIPLOPIA; DIZZINESS; DRUG ERUPTION; DRUG TOXICITY; ECLAMPSIA; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC STATE; FACE DYSMORPHIA; FATIGUE; FETAL WELL BEING; FETUS GROWTH; FETUS MALFORMATION; GENERALIZED EDEMA; GESTATIONAL AGE; GINGIVA HYPERTROPHY; HAIR LOSS; HEART DISEASE; HEMATOLOGIC DISEASE; HIRSUTISM; HUMAN; HYPERTENSION; HYPOSPADIAS; HYPOXEMIA; HYPOXIA; INTELLIGENCE QUOTIENT; INTRAUTERINE GROWTH RETARDATION; LABORATORY TEST; LOADING DRUG DOSE; LOW BIRTH WEIGHT; LOW DRUG DOSE; MAGNESIUM TOXICITY; MAINTENANCE DRUG DOSE; MATERNAL CARE; MATERNAL HYPERTENSION; MICROANGIOPATHY; MUSCLE WEAKNESS; NAUSEA; NEURAL TUBE DEFECT; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; OROFACIAL DYSKINESIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; RECOMMENDED DRUG DOSE; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; REVIEW; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKELETON MALFORMATION; SKIN BRUISING; SMALL FOR DATE INFANT; SOMNOLENCE; SPONTANEOUS ABORTION; SYMPTOMATOLOGY; THROMBOCYTOPENIA; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; VITAMIN SUPPLEMENTATION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84881100784     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2013.04.001     Document Type: Review

References (130)

1. Harden C.L., Meador K.J., Pennell P.B., et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73(2):133-141. [PubMed PMID: 19398681. Pubmed Central PMCID: 3475194].
2. Yerby M.S. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 2000, 55(5 suppl 1):S21-S31. [discussion S54-8. PubMed PMID: 11001359].
3. Krumholz A., Wiebe S., Gronseth G., et al. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2007, 69(21):1996-2007. [PubMed PMID: 18025394].
4. Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004, 104(3):647-651. Practice ACoO. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995), [PubMed PMID: 15339791].
5. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1981 Aug;22(4):489-501. PubMed PMID: 6790275.
6. Viinikainen K., Heinonen S., Eriksson K., Kalviainen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006, 47(1):186-192. [PubMed PMID: 16417548].
7. Richmond J.R., Krishnamoorthy P., Andermann E., Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004, 190(2):371-379. [PubMed PMID: 14981376].
8. Hiilesmaa V.K., Bardy A., Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985, 152(5):499-504. [PubMed PMID: 4014343].
9. Hvas C.L., Henriksen T.B., Ostergaard J.R., Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000, 107(7):896-902. [PubMed PMID: 10901562].
10. Cantwell R., Clutton-Brock T., Cooper G., et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011, 118(suppl 1):1-203. [PubMed PMID: 21356004].
11. Pennell P.B. Pregnancy in the woman with epilepsy: maternal and fetal outcomes. Semin Neurol 2002, 22(3):299-308. [PubMed PMID: 12528055].
12. Harden C.L., Hopp J., Ting T.Y., et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73(2):126-132. [PubMed PMID: 19398682. Pubmed Central PMCID: 3475195].
13. Status Epilepticus in Adults. 2013. Available from: http://www.uptodate.com.
14. Nulman I., Scolnik D., Chitayat D., Farkas L.D., Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 1997, 68(1):18-24. [PubMed PMID: 8986270].
15. Fried S., Kozer E., Nulman I., Einarson T.R., Koren G. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf 2004, 27(3):197-202. [PubMed PMID: 14756581].
16. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006, 77(2):193-198. [PubMed PMID: 16157661. Pubmed Central PMCID: 2077578].
17. Holmes L.B., Harvey E.A., Coull B.A., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001, 344(15):1132-1138. [PubMed PMID: 11297704].
18. Tomson T., Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012, 11(9):803-813. [PubMed PMID: 22805351].
19. Tomson T., Battino D., Bonizzoni E., et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011, 10(7):609-617. [PubMed PMID: 21652013].
20. Meador K.J., Baker G.A., Browning N., et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009, 360(16):1597-1605. [PubMed PMID: 19369666. Pubmed Central PMCID: 2737185].
21. Wlodarczyk B.J., Palacios A.M., George T.M., Finnell R.H. Antiepileptic drugs and pregnancy outcomes. Am J Med Genet Part A 2012, 158A(8):2071-2090. [PubMed PMID: 22711424. Pubmed Central PMCID: 3402584].
22. Harden C.L., Pennell P.B., Koppel B.S., et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009, 73(2):142-149. [PubMed PMID: 19398680. Pubmed Central PMCID: 3475193].
23. Cheschier N. Bulletins-Obstetrics ACoP. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int J Gynaecol Obstet 2003, 83(1):123-133. [PubMed PMID: 14626221].
24. Penovich P.E., Eck K.E., Economou V.V. Recommendations for the care of women with epilepsy. Cleve Clin J Med 2004, 71(suppl 2):S49-S57. [PubMed PMID: 15379300].
25. Pennell P.B., Peng L., Newport D.J., et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008, 70(22 Pt 2):2130-2136. [PubMed PMID: 18046009].
26. Ohman I., Vitols S., Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000, 41(6):709-713. [PubMed PMID: 10840403].
27. Newport D.J., Pennell P.B., Calamaras M.R., et al. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 2008, 122(1):e223-e231. [PubMed PMID: 18591203].
28. Johannessen S.I., Helde G., Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005, 46(5):775-777. [PubMed PMID: 15857447].
29. Ohman I., Vitols S., Luef G., Soderfeldt B., Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002, 43(10):1157-1160. [PubMed PMID: 12366729].
30. Ohman I., Vitols S., Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?. Epilepsia 2005, 46(10):1621-1624. [PubMed PMID: 16190933].
31. Meador K.J., Baker G.A., Browning N., et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010, 75(22):1954-1960. [PubMed PMID: 21106960. Pubmed Central PMCID: 3014232].
32. Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005, 46(suppl 9):117-124. [PubMed PMID: 16302885].
33. International Registry of Antiepileptic Drugs and Pregnancy (EURAP). Available from: http://www.eurapinternational.org/registry/index.php.
34. North American Pregnancy Registry. Available from: http://www.massgeneral.org/aed.
35. UK Epilepsy and Pregnancy Register. Available from: http://www.epilepsyandpregnancy.co.uk/.
36. Cunnington M.C., Weil J.G., Messenheimer J.A., Ferber S., Yerby M., Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 2011, 76(21):1817-1823. [PubMed PMID: 21606453].
37. Hardman J.G.L.L., Gilman A.G. The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York.
38. Hanson J.W., Smith D.W. Fetal hydantoin syndrome. Lancet 1976, 1(7961):692. [PubMed PMID: 73661].
39. Wide K., Henning E., Tomson T., Winbladh B. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 2002, 91(4):409-414. [PubMed PMID: 12061356].
40. Scolnik D., Nulman I., Rovet J., et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. J Am Med Assoc 1994, 271(10):767-770. [PubMed PMID: 7509419].
41. Vanoverloop D., Schnell R.R., Harvey E.A., Holmes L.B. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 1992, 14(5):329-335. [PubMed PMID: 1454041].
42. Tomson T., Lindbom U., Ekqvist B., Sundqvist A. Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia 1994, 35(1):131-135. [PubMed PMID: 8112235].
43. Sabers A., Tomson T. Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 2009, 22(2):157-161. [PubMed PMID: 19532039].
44. Thomas S.V., Ajaykumar B., Sindhu K., et al. Cardiac malformations are increased in infants of mothers with epilepsy. Pediatr Cardiol 2008, 29(3):604-608. [PubMed PMID: 18188637].
45. Hernandez-Diaz SMR, Holmes LB, ed. Risk of major malformations among infants exposed to carbamazepine during pregnancy. 47th Teratology Society Meeting: Birth Defect Research 2010.
46. Werler M.M., Ahrens K.A., Bosco J.L., et al. Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol 2011, 21(11):842-850. [PubMed PMID: 21982488].
47. Holmes L.B., Mittendorf R., Shen A., Smith C.R., Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 2011, 68(10):1275-1281. [PubMed PMID: 21670385].
48. Petrenaite V., Sabers A., Hansen-Schwartz J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 2005, 65(3):185-188. [PubMed PMID: 16084694].
49. Tran T.A., Leppik I.E., Blesi K., Sathanandan S.T., Remmel R. Lamotrigine clearance during pregnancy. Neurology 2002, 59(2):251-255. [PubMed PMID: 12136066].
50. de Haan G.J., Edelbroek P., Segers J., et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004, 63(3):571-573. [PubMed PMID: 15304599].
51. Ohman I., Beck O., Vitols S., Tomson T. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 2008, 49(6):1075-1080. [PubMed PMID: 18076642].
52. Holmes L.B., Baldwin E.J., Smith C.R., et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008, 70(22 Pt 2):2152-2158. [PubMed PMID: 18448870].
53. Tomson T., Palm R., Kallen K., et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007, 48(6):1111-1116. [PubMed PMID: 17381438].
54. Lopez-Fraile I.P., Cid A.O., Juste A.O., Modrego P.J. Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications. Epilepsy Behav 2009, 15(3):372-375. [PubMed PMID: 19362602].
55. Mawhinney E., Craig J., Morrow J., et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013, 80(4):400-405. [PubMed PMID: 23303847].
56. Shallcross R., Bromley R.L., Irwin B., et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011, 76(4):383-389. [PubMed PMID: 21263139. Pubmed Central PMCID: 3271390].
57. Cummings C., Stewart M., Stevenson M., Morrow J., Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011, 96(7):643-647. [PubMed PMID: 21415043].
58. Westin A.A., Nakken K.O., Johannessen S.I., Reimers A., Lillestolen K.M., Brodtkorb E. Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia 2009, 50(3):480-485. [PubMed PMID: 19178558].
59. Ohman I., Sabers A., de Flon P., Luef G., Tomson T. Pharmacokinetics of topiramate during pregnancy. Epilepsy Res 2009, 87(2-3):124-129. [PubMed PMID: 19740626].
60. Hunt S., Russell A., Smithson W.H., et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008, 71(4):272-276. [PubMed PMID: 18645165].
61. Liu S., Joseph K.S., Liston R.M., et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011, 118(5):987-994. [PubMed PMID: 22015865].
62. Callaghan W.M., Creanga A.A., Kuklina E.V. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012, 120(5):1029-1036. [PubMed PMID: 23090519].
63. Dolea C, AbouZahr C, eds. Global Burden of Hypertensive Disorders of Pregnancy in the Year 2000. Geneva: World Health Organisation; 2003.
64. Makhseed M., Musini V.M. Eclampsia in Kuwait 1981-1993. Aust N Z J Obstet Gynaecol 1996, 36(3):258-263. [PubMed PMID: 8883746].
65. Sibai B.M. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990, 163(3):1049-1054. [discussion 54-5; PubMed PMID: 2403130].
66. Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. Br Med J 1994, 309(6966):1395-1400. [PubMed PMID: 7819845. Pubmed Central PMCID: 2541348].
67. Mattar F., Sibai B.M. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000, 182(2):307-312. [PubMed PMID: 10694329].
68. Katz V.L., Farmer R., Kuller J.A. Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol 2000, 182(6):1389-1396. [PubMed PMID: 10871454].
69. Chames M.C., Livingston J.C., Ivester T.S., Barton J.R., Sibai B.M. Late postpartum eclampsia: a preventable disease?. Am J Obstet Gynecol 2002, 186(6):1174-1177. [PubMed PMID: 12066093].
70. Dahmus M.A., Barton J.R., Sibai B.M. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol 1992, 167(4 Pt 1):935-941. [PubMed PMID: 1415428].
71. Cunningham F.G., Twickler D. Cerebral edema complicating eclampsia. Am J Obstet Gynecol 2000, 182(1 Pt 1):94-100. [PubMed PMID: 10649162].
72. Schwartz R.B., Feske S.K., Polak J.F., et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000, 217(2):371-376. [PubMed PMID: 11058630].
73. Thornton C.E., Dahlen H., Korda A., Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population linked datasets: 2000-2008. Am J Obstet Gynecol 2013, 1. [PubMed PMID: 23467048].
74. Lubarsky S.L., Barton J.R., Friedman S.A., Nasreddine S., Ramadan M.K., Sibai B.M. Late postpartum eclampsia revisited. Obstet Gynecol 1994, 83(4):502-505. [PubMed PMID: 8134057].
75. Moller B., Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand 1986, 65(4):307-314. [PubMed PMID: 3739642].
76. Pritchard J.A., Cunningham F.G., Pritchard S.A. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984, 148(7):951-963. [PubMed PMID: 6711634].
77. Leitch C.R., Cameron A.D., Walker J.J. The changing pattern of eclampsia over a 60-year period. Br J Obstet Gynecol 1997, 104(8):917-922. [PubMed PMID: 9255083].
78. Richards A.M., Moodley J., Graham D.I., Bullock M.R. Active management of the unconscious eclamptic patient. Br J Obstet Gynecol 1986, 93(6):554-562. [PubMed PMID: 3730324].
79. Lopez-Llera M. Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol 1992, 166(1 Pt 1):4-9. [PubMed PMID: 1733215].
80. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995 Jun 10;345(8963):1455-63. PubMed PMID: 7769899.
81. Beck D.W., Menezes A.H. Intracerebral hemorrhage in a patient with eclampsia. J Am Med Assoc 1981, 246(13):1442-1443. [PubMed PMID: 7265450].
82. Martin J.N., Thigpen B.D., Moore R.C., Rose C.H., Cushman J., May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005, 105(2):246-254. [PubMed PMID: 15684147].
83. Altman D., Carroli G., Duley L., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359(9321):1877-1890. [PubMed PMID: 12057549].
84. Belfort M.A., Anthony J., Saade G.R., Allen J.C. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003, 348(4):304-311. Nimodipine Study G, [PubMed PMID: 12540643].
85. Lucas M.J., Leveno K.J., Cunningham F.G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995, 333(4):201-205. [PubMed PMID: 7791836].
86. Duley L., Gulmezoglu A.M., Henderson-Smart D.J., Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010, 11:CD000025. [PubMed PMID: 21069663].
87. Witlin A.G., Sibai B.M. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998, 92(5):883-889. [PubMed PMID: 9794688].
88. Sibai B.M. Management of Eclampsia. Management of Acute Obstetric Emergencies 2011, 115-123. Saunders, Philadelphia, PA.
89. ACOG Practice Bulletin No. 125: chronic hypertension in pregnancy. Obstet Gynecol 2012, 119(2 Pt 1):396-407. American College of Obstetricians and Gynecologists, [PubMed PMID: 22270315].
90. Committee on Obstetric Practice Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol 2011, 118(6):1465-1468. [PubMed PMID: 22105295].
91. Magee L.A., Cham C., Waterman E.J., Ohlsson A., von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. Br Med J 2003, 327(7421):955-960. [PubMed PMID: 14576246. Pubmed Central PMCID: 259162].
92. Raheem I.A., Saaid R., Omar S.Z., Tan P.C. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG 2012, 119(1):78-85. [PubMed PMID: 21985500].
93. Menzies J., Magee L.A., Li J., et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007, 110(1):121-127. [PubMed PMID: 17601906].
94. von Dadelszen P., Sawchuck D., McMaster R., et al. The active implementation of pregnancy hypertension guidelines in British Columbia. Obstet Gynecol 2010, 116(3):659-666. [PubMed PMID: 20733449].
95. Paul R.H., Koh K.S., Bernstein S.G. Changes in fetal heart rate-uterine contraction patterns associated with eclampsia. Am J Obstet Gynecol 1978, 130(2):165-169. [PubMed PMID: 619657].
96. Sibai B.M., Mabie B.C., Harvey C.J., Gonzalez A.R. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 1987, 156(5):1174-1179. [PubMed PMID: 3578433].
97. Barton J.R., Hiett A.K., Conover W.B. The use of nifedipine during the postpartum period in patients with severe preeclampsia. Am J Obstet Gynecol 1990, 162(3):788-792. [PubMed PMID: 2316590].
98. Ben-Ami M., Giladi Y., Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynecol 1994, 101(3):262-263. [PubMed PMID: 8193107].
99. Snyder S.W., Cardwell M.S. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989, 161(1):35-36. [PubMed PMID: 2750819].
100. Kuklina E.V., Tong X., Bansil P., George M.G., Callaghan W.M. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern?. Stroke 2011, 42(9):2564-2570. [PubMed PMID: 21799174].
101. Salonen Ros H., Lichtenstein P., Bellocco R., Petersson G., Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001, 12(4):456-460. [PubMed PMID: 11416782].
102. Kittner S.J., Stern B.J., Feeser B.R., et al. Pregnancy and the risk of stroke. N Engl J Med 1996, 335(11):768-774. [PubMed PMID: 8703181. Pubmed Central PMCID: 1479545].
103. Jaigobin C., Silver F.L. Stroke and pregnancy. Stroke 2000, 31(12):2948-2951. [PubMed PMID: 11108754].
104. James A.H., Bushnell C.D., Jamison M.G., Myers E.R. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005, 106(3):509-516. [PubMed PMID: 16135580].
105. Lanska D.J., Kryscio R.J. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000, 31(6):1274-1282. [PubMed PMID: 10835444].
106. Sharshar T., Lamy C., Mas J.L. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995, 26(6):930-936. [PubMed PMID: 7762040].
107. Wiebers D.O. Ischemic cerebrovascular complications of pregnancy. Arch Neurol 1985, 42(11):1106-1113. [PubMed PMID: 2864911].
108. Petitti D.B., Sidney S., Quesenberry C.P., Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997, 28(2):280-283. [PubMed PMID: 9040675].
109. Dias M.S., Sekhar L.N. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990, 27(6):855-865. [discussion 65-6; PubMed PMID: 2274125].
110. Fox M.W., Harms R.W., Davis D.H. Selected neurologic complications of pregnancy. Mayo Clin Proc 1990, 65(12):1595-1618. [PubMed PMID: 2255222].
111. Donaldson J.O. Neurologic emergencies in pregnancy. Obstet Gynecol Clin North Am 1991, 18(2):199-212. [PubMed PMID: 1945251].
112. Witlin A.G., Friedman S.A., Egerman R.S., Frangieh A.Y., Sibai B.M. Cerebrovascular disorders complicating pregnancy-beyond eclampsia. Am J Obstet Gynecol 1997, 176(6):1139-1145. [discussion 45-8; PubMed PMID: 9215166].
113. Donaldson J.O., Lee N.S. Arterial and venous stroke associated with pregnancy. Neurol Clin 1994, 12(3):583-599. [PubMed PMID: 7990792].
114. Webster M.W., Chancellor A.M., Smith H.J., et al. Patent foramen ovale in young stroke patients. Lancet 1988, 2(8601):11-12. [PubMed PMID: 2898621].
115. Witlin A.G., Mattar F., Sibai B.M. Postpartum stroke: a twenty-year experience. Am J Obstet Gynecol 2000, 183(1):83-88. [PubMed PMID: 10920313].
116. Cantu C., Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993, 24(12):1880-1884. [PubMed PMID: 8248971].
117. Coutinho J.M., Ferro J.M., Canhao P., et al. Cerebral venous and sinus thrombosis in women. Stroke 2009, 40(7):2356-2361. [PubMed PMID: 19478226].
118. Horton J.C., Chambers W.A., Lyons S.L., Adams R.D., Kjellberg R.N. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990, 27(6):867-871. [discussion 71-2; PubMed PMID: 2274126].
119. Sadasivan B., Malik G.M., Lee C., Ausman J.I. Vascular malformations and pregnancy. Surg Neurol 1990, 33(5):305-313. [PubMed PMID: 2330531].
120. Wiebers D.O. Subarachnoid hemorrhage in pregnancy. Semin Neurol 1988, 8(3):226-229. [PubMed PMID: 3057554].
121. Sundt T.M., Whisnant J.P. Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease. N Engl J Med 1978, 299(3):116-122. [PubMed PMID: 661871].
122. Sattar A., Manousakis G., Jensen M.B. Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 2010, 8(10):1417-1421. [PubMed PMID: 20936928. Pubmed Central PMCID: 3020907].
123. Fletcher J.J., Kramer A.H., Bleck T.P., Solenski N.J. Overlapping features of eclampsia and postpartum angiopathy. Neurocrit Care 2009, 11(2):199-209. [PubMed PMID: 19404782].
124. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334(8):494-500. [PubMed PMID: 8559202].
125. Bakhru A., Atlas R.O. A case of postpartum cerebral angiitis and review of the literature. Arch Gynecol Obstet 2011, 283(3):663-668. [PubMed PMID: 20419307].
126. Mas J.L., Lamy C. Stroke in pregnancy and the puerperium. J Neurol 1998, 245(6-7):305-313. [PubMed PMID: 9669480].
127. Donnan G.A. Investigation of patients with stroke and transient ischaemic attacks. Lancet 1992, 339(8791):473-477. [PubMed PMID: 1346828].
128. Tettenborn B. Stroke and pregnancy. Neurol Clin 2012, 30(3):913-924. [PubMed PMID: 22840796].
129. Einhaupl K.M., Villringer A., Meister W., et al. Heparin treatment in sinus venous thrombosis. Lancet 1991, 338(8767):597-600. [PubMed PMID: 1679154].
130. Robinson J.L., Hall C.S., Sedzimir C.B. Arteriovenous malformations, aneurysms, and pregnancy. J Neurosurg 1974, 41(1):63-70. [PubMed PMID: 4858207].